On March 27, 2026, PAVmed Inc. held a Special Meeting of stockholders where they approved the issuance of common stock related to Series D Preferred Stock and convertible notes, an amendment to the Certificate of Incorporation regarding director removal, and an increase in shares available under the 2014 Long-Term Incentive Equity Plan.
Key takeaways
Stockholders approved the issuance of shares upon conversion of 60,000 shares of Series D Convertible Preferred Stock and pursuant to an Amended and Restated Senior Secured Convertible Note.
An amendment to the Certificate of Incorporation was approved to permit the removal of directors with or without cause by a majority vote; the amendment was effective March 27, 2026.
The 2014 Long-Term Incentive Equity Plan was amended to increase the share reserve by 1,500,000 shares, raising the total to 1,713,517 shares.
Stockholders representing approximately 54.1% of the voting power outstanding were present at the Special Meeting.
The Charter Amendment Proposal passed with 858,651 votes 'For' and 60,825 votes 'Against'.